Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
- PMID: 35081300
- PMCID: PMC8809508
- DOI: 10.1056/NEJMc2119407
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
References
-
- World Health Organization. Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update. December 7, 2021. (https://www.who.int/publications/m/item/weekly-epidemiological-update-on...).
-
- Qin S, Cui M, Sun S, et al. Genome characterization and potential risk assessment of the novel SARS-CoV-2 variant omicron (B.1.1.529). Zoonoses, December 3, 2021. (https://www.scienceopen.com/hosted-document?doi=10.15212/ZOONOSES-2021-0024).
-
- Planas D, Veyer D, Baidaliuk A, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 2021;596:276-280. - PubMed
-
- Bansal K, Kumar S. Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant. December 7, 2021. (https://www.biorxiv.org/content/10.1101/2021.12.06.471389v1). preprint. - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources